• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

肝硬化患者接受肝移植后出现血小板减少、脾肿大和门静脉血流。

Thrombocytopenia, splenomegaly, and portal blood flow in patients who have undergone liver transplantation for cirrhosis.

机构信息

Department of Anesthesiology and Critical Care, Pitié-Salpêtrière Hospital, Public Hospital System of Paris, Pierre and Marie Curie University, Paris, France.

出版信息

Liver Transpl. 2012 Mar;18(3):340-6. doi: 10.1002/lt.22456.

DOI:10.1002/lt.22456
PMID:22006447
Abstract

The platelet count (PC), the spleen size (SS), and the portal blood flow (PBF) have been independently studied in the perioperative period after orthotopic liver transplantation (OLT) for cirrhosis, but these parameters have not been described and analyzed in combination. We analyzed PC data and Doppler sonography measurements of SS and PBF from 125 adult patients before OLT and 1, 3, 6, 9, and 12 months after transplantation. A linear mixed model with fixed subject random intercepts was used. PCs increased significantly from 101.5 ± 68.5 × 10(9) /L before OLT to 162.4 ± 86 × 10(9) /L 1 month after OLT and remained stable for 1 year after the operation. PBF increased significantly from 619 ± 239 mL/minute before OLT to 1379 ± 491 mL/minute after OLT and remained stable during the first year. SS slowly decreased after OLT, but the decrease became significant only 9 months after the operation (13.8 ± 4.2 cm before OLT versus 11.7 ± 3.7 cm at 9 months, P < 0.05). The cirrhosis etiology did not influence the evolution of the parameters. With or without replication or interferon treatment before OLT, the hepatitis C group viruses did not influence PCs postoperatively. The evolution of SS was correlated to the evolution of PCs in the year after transplantation. In conclusion, PCs and PBF increase rapidly after OLT, whereas SS slowly decreases. The cirrhosis etiology does not influence the evolution of PCs. Thrombocytopenia and splenomegaly are 2 results of portal hypertension, but the rapid normalization of PBF does not completely or rapidly reverse these 2 phenomena.

摘要

血小板计数(PC)、脾脏大小(SS)和门静脉血流(PBF)已在肝硬化患者原位肝移植(OLT)围手术期进行了独立研究,但这些参数尚未结合在一起进行描述和分析。我们分析了 125 例成年患者在OLT 前和移植后 1、3、6、9 和 12 个月的 PC 数据和 SS 和 PBF 的多普勒超声测量值。使用具有固定受试者随机截距的线性混合模型。PC 从 OLT 前的 101.5±68.5×10^9/L 显著增加到 OLT 后 1 个月的 162.4±86×10^9/L,并在手术后 1 年内保持稳定。PBF 从 OLT 前的 619±239mL/min 显著增加到 OLT 后的 1379±491mL/min,并在第一年保持稳定。SS 在 OLT 后缓慢下降,但仅在手术后 9 个月时下降才有统计学意义(OLT 前为 13.8±4.2cm,OLT 后为 11.7±3.7cm,P<0.05)。肝硬化病因并不影响参数的演变。OLT 前是否复制或干扰素治疗,丙型肝炎病毒对术后 PC 均无影响。SS 的演变与移植后 1 年内的 PC 演变相关。总之,PC 和 PBF 在 OLT 后迅速增加,而 SS 则缓慢下降。肝硬化病因不影响 PC 的演变。血小板减少症和脾肿大是门静脉高压的两个结果,但 PBF 的快速正常化并不能完全或迅速逆转这两个现象。

相似文献

1
Thrombocytopenia, splenomegaly, and portal blood flow in patients who have undergone liver transplantation for cirrhosis.肝硬化患者接受肝移植后出现血小板减少、脾肿大和门静脉血流。
Liver Transpl. 2012 Mar;18(3):340-6. doi: 10.1002/lt.22456.
2
Differences in portal hemodynamics between whole liver transplantation and living donor liver transplantation.全肝移植与活体肝移植后门静脉血流动力学的差异。
Liver Transpl. 2010 Nov;16(11):1236-41. doi: 10.1002/lt.22138.
3
[A clinical study on splanchnic hemodynamic changes after orthotopic liver transplantation for patients with portal hypertension].门静脉高压症患者原位肝移植术后内脏血流动力学变化的临床研究
Zhonghua Wai Ke Za Zhi. 2008 Nov 15;46(22):1699-702.
4
Systemic and splanchnic hemodynamic changes after liver transplantation for cirrhosis: a long-term prospective study.肝硬化肝移植术后全身及内脏血流动力学变化:一项长期前瞻性研究。
Hepatology. 1999 Jul;30(1):58-64. doi: 10.1002/hep.510300112.
5
Hemodynamics of portal venous stenosis before and after treatment in pediatric liver transplantation: evaluation with Doppler ultrasound.小儿肝移植中门静脉狭窄治疗前后的血流动力学:多普勒超声评估
Transplant Proc. 2012 Mar;44(2):481-3. doi: 10.1016/j.transproceed.2012.01.047.
6
[Splenomegaly and hypersplenism in cirrhotic patients before and after orthotopic liver transplantation].原位肝移植前后肝硬化患者的脾肿大与脾功能亢进
Radiol Med. 1998 Apr;95(4):349-52.
7
Hemodynamic changes in splanchnic circulation after orthotopic liver transplantation in patients with liver cirrhosis.
Abdom Imaging. 2002 Sep-Oct;27(5):541-5. doi: 10.1007/s00261-001-0101-0.
8
Alterations in glucose metabolism associated with liver cirrhosis persist in the clinically stable long-term course after liver transplantation.与肝硬化相关的葡萄糖代谢改变在肝移植后的临床稳定长期病程中持续存在。
Liver Transpl. 2004 Aug;10(8):1030-40. doi: 10.1002/lt.20147.
9
Change in portal flow after liver transplantation: effect on hepatic arterial resistance indices and role of spleen size.肝移植后门静脉血流变化:对肝动脉阻力指数的影响及脾脏大小的作用
Hepatology. 2002 Mar;35(3):601-8. doi: 10.1053/jhep.2002.31352.
10
Temporary portocaval shunt during liver transplantation with vena cava preservation. Results of a prospective randomized study.肝移植术中保留腔静脉的临时性门腔分流术。一项前瞻性随机研究的结果
Liver Transpl. 2001 Oct;7(10):904-11. doi: 10.1053/jlts.2001.27870.

引用本文的文献

1
Low platelet count: Predictor of death and graft loss after liver transplantation.血小板计数低:肝移植后死亡和移植物丢失的预测指标。
World J Hepatol. 2019 Jan 27;11(1):99-108. doi: 10.4254/wjh.v11.i1.99.
2
MR angiography and 2-D phase-contrast imaging for evaluation of meso-rex bypass function.磁共振血管造影和二维相位对比成像用于评估肠系膜上静脉-门静脉分流术的功能。
Pediatr Radiol. 2019 Feb;49(2):168-174. doi: 10.1007/s00247-018-4284-8. Epub 2018 Oct 31.
3
Hypersplenism in liver disease and SLE revisited: current evidence supports an active rather than passive process.
再探肝病和系统性红斑狼疮中的脾功能亢进:当前证据支持其为一个主动而非被动的过程。
BMC Hematol. 2016 Feb 9;16:3. doi: 10.1186/s12878-016-0042-z. eCollection 2016.
4
Immediate Postoperative Low Platelet Counts After Living Donor Liver Transplantation Predict Early Allograft Dysfunction.活体肝移植术后即刻血小板计数低预示早期移植物功能障碍。
Medicine (Baltimore). 2015 Aug;94(34):e1373. doi: 10.1097/MD.0000000000001373.
5
Use of analytic morphomics of liver, spleen, and body composition to identify patients at risk for cirrhosis.利用肝脏、脾脏的分析形态学和身体成分来识别有肝硬化风险的患者。
Clin Gastroenterol Hepatol. 2015 Feb;13(2):360-368.e5. doi: 10.1016/j.cgh.2014.07.042. Epub 2014 Jul 30.